ANL vs APLM

Adlai Nortye Ltd. vs Apollomics Inc. — Valuation Comparison 2026

ANL

Pharmaceutical Preparations
Adlai Nortye Ltd.
Quality
1.5
out of 10
Value Trap
12
SAFE
Price
$11.94
Last close
Models
9/13
Active
VS

APLM

Pharmaceutical Preparations
Apollomics Inc.
Quality
1.8
out of 10
Value Trap
Price
$14.15
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType ANL Fair ValueANL Upside APLM Fair ValueAPLM Upside
Bayesian DCF Intrinsic $3.00 -74.8% $3.73 -73.6%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $20.40 +70.9% $12.28 -13.2%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $7.86 -49.3%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ANL vs APLM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ANL vs APLM — Which Stock Is More Undervalued?

APLM scores higher with a 1.8/10 quality rating vs ANL's 1.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Adlai Nortye Ltd. (ANL) and Apollomics Inc. (APLM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ANL currently trades at $11.94 with a QOC of 1.5/10, while APLM trades at $14.15 with a QOC of 1.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).